Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros

Banco de datos
País/Región como asunto
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Microb Pathog ; 98: 45-9, 2016 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-27354207

RESUMEN

Dental caries is caused by acids produced by biofilm-forming Streptococcus mutans from fermentable carbohydrates and bacterial byproducts. Control of these bacteria is important in the prevention of dental caries. This study investigated the effect of the fruit peel of Punica granatum on biofilm formation, acid and extracellular polysaccharides production (EPS) by S. mutans. Pomegranate fruit peels crude extracts were prepared. The Minimum bactericidal concentrations (MBC) were determined against S. mutans. At 3 sub-bactericidal concentrations, the effect on the acid production, biofilm formation and EPS production was determined. The results were analysed using Kruskal-Wallis and Wilcoxon Rank Sum Tests. The lowest MBC was 6.25 mg/mL. Punica granatum significantly inhibited acid production (p < 0.01). After 6 and 24 h, it significantly reduced biofilm-formation by 91% and 65% respectively (p < 0.01). The plant extract did not inhibit the production of soluble EPS in either the biofilm or the planktonic growth. However, it significantly reduced the insoluble EPS in the biofilm and the plantktonic (p = < 0.01) form of S. mutans. The crude extract of P. granatum killed cariogenic S. mutans at high concentrations. At sub-bactericidal concentrations, it reduced biofilm formation, acid and EPS production. This suggests that P. granatum extract has the potential to prevent dental caries.


Asunto(s)
Antibacterianos/farmacología , Biopelículas/efectos de los fármacos , Lythraceae/química , Fitoquímicos/farmacología , Extractos Vegetales/farmacología , Streptococcus mutans/efectos de los fármacos , Factores de Virulencia/metabolismo , Antibacterianos/aislamiento & purificación , Biopelículas/crecimiento & desarrollo , Ácidos Carboxílicos/metabolismo , Viabilidad Microbiana/efectos de los fármacos , Fitoquímicos/aislamiento & purificación , Extractos Vegetales/aislamiento & purificación , Polisacáridos Bacterianos/metabolismo , Streptococcus mutans/crecimiento & desarrollo , Streptococcus mutans/metabolismo , Streptococcus mutans/fisiología
2.
J Med Virol ; 83(2): 235-44, 2011 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-21181917

RESUMEN

Hepatitis B virus (HBV) is endemic in Africa, being hyperendemic in sub-Saharan Africa. Genotypes A, D, and E circulate in Africa, showing a distinct geographical distribution. The aim of the present study was to determine the HBV genotype distribution in blood donors from different geographical locations in Zimbabwe. Using a restriction fragment polymorphism assay, sequencing of the basic core promoter/precore region and of the complete S open reading frame showed that 29 HBV isolates from geographically distinct regions belong to subgenotype A1. The complete genome of two of these Zimbabwean HBV isolates was sequenced. Forty-four percent of the Zimbabwean HBV isolates (11/23) were characterized by a G1862C missense mutation, which causes a Val to Leu amino acid substitution at position 17 of the precore region. The majority of Zimbabwean HBV isolates clustered with a number of South African HBV isolates, with which they shared characteristic amino acids in the preS1, preS2, and polymerase spacer regions. The wide distribution of subgenotype in Africa, as well as the high intragroup divergence and the geographical clustering of the African and Asian subgenotype A1 HBV isolates indicate that this subgenotype has a long period of endemicity in these regions.


Asunto(s)
Donantes de Sangre , Virus de la Hepatitis B/genética , Hepatitis B/virología , Adolescente , Adulto , Femenino , Genoma Viral , Hepatitis B/epidemiología , Antígenos del Núcleo de la Hepatitis B/genética , Antígenos de Superficie de la Hepatitis B/genética , Virus de la Hepatitis B/clasificación , Humanos , Masculino , Datos de Secuencia Molecular , Sistemas de Lectura Abierta/genética , Filogenia , Polimorfismo de Longitud del Fragmento de Restricción , Regiones Promotoras Genéticas/genética , Zimbabwe/epidemiología
3.
J Ethnopharmacol ; 144(1): 171-4, 2012 Oct 31.
Artículo en Inglés | MEDLINE | ID: mdl-22981723

RESUMEN

ETHNOPHARMACOLOGICAL RELEVANCE: The leaves of Dodonaea viscosa var. angustifolia (DVA) are traditionally used for the treatment of fever, colds, oral thrush, toothaches and related problems. Streptococcus mutans is implicated in many oral infections. This study investigated the inhibitory activity of DVA extract against Streptococcus mutans and its biofilm. MATERIALS AND METHODS: Crude extract of the leaves was prepared using methanol. The time-kill curve for Streptococcus mutans at different concentrations of methanol extract after 6 and 24 h was determined. Biofilms of Streptococcus mutans were grown in the presence of subinhibitory concentration of extract (0.78 mg/ml) for 30 h and the bacterial counts were obtained after 6, 24 and 30 h. The chemical profile of the crude extract was obtained using gas chromatography-mass spectrometry (GC-MS). RESULTS: The reduction of Streptococcus mutans was concentration and exposure time dependent. The crude extract killed 48% of S. mutans at a lowest concentration of 0.1 mg/ml and 100% at 25 mg/ml after 6h. Biofilm formation was reduced by 95, 97 and 99% after 6, 24 and 30 h of exposure to the subinhibitory concentration of crude extract respectively. GC-MS analyses revealed the presence of polyphenols such as catechin or chromene groups, chalcones with trimethoxyphenyl group and tannin with 4-O-ß-D-xylopyranoside. At high concentration the crude extract was bactericidal to Streptococcus mutans but subinhibitory concentration significantly reduced the planktonic cells and biofilm formation. CONCLUSIONS: These results suggest that this plant has the potential to be used to control S. mutans and its biofilm which are responsible for oral infections.


Asunto(s)
Antibacterianos/farmacología , Extractos Vegetales/farmacología , Sapindaceae , Streptococcus mutans/efectos de los fármacos , Biopelículas/efectos de los fármacos , Recuento de Colonia Microbiana , Hojas de la Planta , Streptococcus mutans/fisiología
4.
J Ethnopharmacol ; 124(3): 562-5, 2009 Jul 30.
Artículo en Inglés | MEDLINE | ID: mdl-19450675

RESUMEN

AIM OF THE STUDY: This study investigated effect of a crude extract of Dodonaea viscosa on the proteinase and phospholipase production and adherence to epithelial cells by Candida albicans isolated from HIV positive and HIV negative patients. MATERIALS AND METHODS: Twenty Candida albicans strains isolated from HIV positive and 20 from HIV negative patients were investigated. The isolates were exposed to subinhibitory concentration of crude plant extract and adherence, proteinase and phospholipase production were assessed. The results were analysed using Student's t-test and a two-way ANOVA. RESULTS: Dodonaea viscosa var. angustifolia inhibited the adherence of Candida albicans to oral epithelial cells (p=<0.01) but no significant effect of the plant extract on proteinase and phospholipase production was observed. Results from Candida albicans strains isolated from HIV positive and HIV negative patients were similar. CONCLUSIONS: Dodonaea viscosa var. angustifolia inhibited the adherence of Candida albicans to oral epithelial cells, which is the initial step of colonization in the infection process. This plant has a therapeutic potential at subinhibitory concentration.


Asunto(s)
Candida albicans/enzimología , Células Epiteliales/efectos de los fármacos , Células Epiteliales/enzimología , Péptido Hidrolasas/biosíntesis , Fosfolipasas/biosíntesis , Sapindaceae/química , Candida albicans/efectos de los fármacos , Adhesión Celular/efectos de los fármacos , Seropositividad para VIH/patología , Humanos , Mucosa Bucal/citología , Extractos Vegetales/farmacología , Hojas de la Planta/química
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA